These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1293 related items for PubMed ID: 25111852
1. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice. Gou S, Zhu T, Wang W, Xiao M, Wang XC, Chen ZH. Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852 [Abstract] [Full Text] [Related]
2. [The Study of the Effect and Mechanism of Glucagon Like Peptide-1 in Bleomycin-induced Pulmonary Fibrosis in Mice]. Liu M, Gou S, Chen HT, Chen ZH. Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):509-514. PubMed ID: 28752966 [Abstract] [Full Text] [Related]
3. Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice. Zhu T, Zhang W, Xiao M, Chen H, Jin H. Int J Mol Sci; 2013 Dec 03; 14(12):23581-96. PubMed ID: 24300094 [Abstract] [Full Text] [Related]
8. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway. Song C, He L, Zhang J, Ma H, Yuan X, Hu G, Tao L, Zhang J, Meng J. J Cell Mol Med; 2016 Nov 30; 20(11):2064-2077. PubMed ID: 27306439 [Abstract] [Full Text] [Related]
9. Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats. Xu L, Li LC, Zhao P, Qi LW, Li P, Gao J, Fei GH. J Pharm Pharmacol; 2014 Dec 30; 66(12):1786-95. PubMed ID: 25209833 [Abstract] [Full Text] [Related]
13. Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice. Zhu T, Wu XL, Zhang W, Xiao M. Int J Mol Sci; 2015 Aug 26; 16(9):20195-211. PubMed ID: 26343632 [Abstract] [Full Text] [Related]
14. Total extract of Yupingfeng attenuates bleomycin-induced pulmonary fibrosis in rats. Li L, Li D, Xu L, Zhao P, Deng Z, Mo X, Li P, Qi L, Li J, Gao J. Phytomedicine; 2015 Jan 15; 22(1):111-9. PubMed ID: 25636879 [Abstract] [Full Text] [Related]
15. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways. Dong SH, Liu YW, Wei F, Tan HZ, Han ZD. Biomed Pharmacother; 2017 May 15; 89():1297-1309. PubMed ID: 28320097 [Abstract] [Full Text] [Related]
16. S-allyl-l-cysteine attenuates bleomycin-induced pulmonary fibrosis and inflammation via AKT/NF-κB signaling pathway in mice. Nie Y, Yu K, Li B, Hu Y, Zhang H, Xin R, Xiong Y, Zhao P, Chai G. J Pharmacol Sci; 2019 Apr 15; 139(4):377-384. PubMed ID: 30928090 [Abstract] [Full Text] [Related]
17. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats. Li S, Yang X, Li W, Li J, Su X, Chen L, Yan G. Respiration; 2012 Apr 15; 84(6):509-17. PubMed ID: 23006535 [Abstract] [Full Text] [Related]
18. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. Kyung SY, Kim DY, Yoon JY, Son ES, Kim YJ, Park JW, Jeong SH. BMC Pharmacol Toxicol; 2018 Apr 02; 19(1):13. PubMed ID: 29609658 [Abstract] [Full Text] [Related]
19. Preventive effects of Ecliptae Herba extract and its component, ecliptasaponin A, on bleomycin-induced pulmonary fibrosis in mice. You XY, Xue Q, Fang Y, Liu Q, Zhang CF, Zhao C, Zhang M, Xu XH. J Ethnopharmacol; 2015 Dec 04; 175():172-80. PubMed ID: 26385580 [Abstract] [Full Text] [Related]
20. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway. Jia L, Sun P, Gao H, Shen J, Gao Y, Meng C, Fu S, Yao H, Zhang G. J Pharm Pharmacol; 2019 Jun 04; 71(6):1017-1028. PubMed ID: 30847938 [Abstract] [Full Text] [Related] Page: [Next] [New Search]